Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 3, 2025 • 7:01 PM ET

Date/Time Source News Release
04/02/2025 08:02 AM EDT PR Newswire Hoth Therapeutics Collaborates with Washington University on NIH Grant Application Advancing Alzheimer's Program Using NK-1 Receptor Antagonist HT-ALZ
04/02/2025 07:58 AM EDT PR Newswire Hoth Therapeutics Announces Positive Pre Clinical Data HT-ALZ Shows Promising Breakthrough in Alzheimer's Disease Research Acute treatment with HT-ALZ led to a rapid (~15%) reduction in brain interstitial fluid A? levels, within 20 hours
03/31/2025 04:45 PM EDT PR Newswire Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage
03/26/2025 08:02 AM EDT PR Newswire Hoth Therapeutics Advances Cancer Fighting HT-KIT Program with New Patent Filing and Preclinical Study Initiation
03/18/2025 08:06 AM EDT PR Newswire Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment
03/10/2025 08:02 AM EDT PR Newswire Hoth Therapeutics Announces Plans to Submit Expanded Access Application for HT-001 to Support Cancer Patients in Need
03/05/2025 01:40 PM EST PR Newswire Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American Academy of Dermatology 2025 Annual Meeting
03/04/2025 08:16 AM EST PR Newswire Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease
02/10/2025 08:22 AM EST PR Newswire Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
01/24/2025 08:29 AM EST PR Newswire Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements
Page

Additional News

As of April 3, 2025 • 7:01 PM ET

Date/Time Source News Release
04/02/2025 09:58 AM EDT Baystreet Hoth Flat on Hookup with Washington Univ.
03/27/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 27th, 2025
03/27/2025 05:30 AM EDT US Earnings Reports Expected earnings - Hoth Therapeutics Inc.
03/10/2025 09:52 AM EDT Baystreet Hoth Dips on Drug Application
03/05/2025 08:53 AM EST 24/7 Market News Hoth Therapeutics Unveils GDNF Breakthrough Data
01/24/2025 08:48 AM EST SeekingAlpha Hoth Therapeutics regains compliance with Nasdaq
01/16/2025 09:17 AM EST Baystreet The Trump Effect: Crypto Diversification Accelerates Across Industries
01/09/2025 01:48 PM EST Zacks Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More
01/08/2025 10:41 AM EST Zacks HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal
01/07/2025 03:15 PM EST KlickAnalytics Buy Recommendation Issued On HOTH By Citigroup
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.